PALADIN Study in Diabetic Eye Disease

Victor H. Gonzalez, MD

Show Description +

Victor H. Gonzalez, MD, discusses the PALADIN study, an ongoing phase 4 study evaluating the safety and efficacy of the fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) as used in the real world in patients with diabetic eye disease. Dr. Gonzalez shares data regarding visual function, anatomic measures, and rates of rescue treatment from a 24-month readout.

Posted: 5/13/2020

Keywords:

Clinical Cases

•

Diabetic Eye Disease

•

fluocinolone acetonide implant

•

Retinal Implants

•

retina-meeting-recap

Up Next

Name: PALADIN Study in Diabetic Eye Disease
Uploaded: 2020-05-13T14:06:00+00:00
Description: Victor H. Gonzalez, MD, discusses the PALADIN study, an ongoing phase 4 study evaluating the safety and efficacy of the fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) as used in the real world in patients with diabetic eye disease. Dr. Gonzalez shares data regarding visual function, anatomic measures, and rates of rescue treatment from a 24-month readout.